HistoRx is developing unique theranostic solutions to unlock new approaches to individualized patient care. HistoRx’s proprietary technology delivers objective and reproducible multiparametric analysis of proteins in tissue, providing new insights into cancer treatment. The Company is applying this expertise to build a proprietary pipeline of diagnostic candidates and to help biopharmaceutical customers advance their drug development programs